PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 8, 2020Cancer CytopathologyOpen Access

ThyroSeq v3 for Bethesda III and IV: An institutional experience

View Full Paper
Ask AI
Bookmark
Share

Authors

DDDimpi DesaiMLMarcos LepeZBZubair Baloch

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Desai et al. (2020) studied this question.

synapsesocial.com/papers/69d89095e9c100a435ae2d8chttps://doi.org/10.1002/cncy.22362
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Role of the ThyroSeq v3 Molecular Test in the Surgical Management of Thyroid Nodules in the Canadian Public Health Care Setting2020 · 59 citations
  2. 2The Bethesda System for Reporting Thyroid Cytopathology2009 · 2,046 citations
  3. 3Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples2011 · 791 citations
  4. 4The 2017 Bethesda System for Reporting Thyroid Cytopathology2017 · 1,870 citations